IOL Chemicals and Pharmaceuticals Announcements
Submission of newspaper publication
13 Apr, 2026 | 03:12pm • Source: BSE
Submission of Newspaper publication
10 Apr, 2026 | 12:37pm • Source: BSE
Disclosure under Regulation 30
09 Apr, 2026 | 02:58pm • Source: BSE
Compliance Certificate under Regulation 74
04 Apr, 2026 | 01:25pm • Source: BSE
Disclosure under SEBI (PIT) Regulations
20 Mar, 2026 | 12:58pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd & PACs
20 Mar, 2026 | 11:38am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mayadevi Polycot Ltd & PACs
18 Mar, 2026 | 03:18pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd & PACs
18 Mar, 2026 | 03:13pm • Source: BSE
Disclosure under SEBI (PIT) Regulations
18 Mar, 2026 | 03:12pm • Source: BSE
CEP Certificate for "METFORMIN HYDROCHLORIDE Process-II"
06 Mar, 2026 | 03:58pm • Source: BSE
CEP Certificate for Clopidogrel Besilate
24 Feb, 2026 | 05:34pm • Source: BSE
Newspaper Publication
18 Feb, 2026 | 02:30pm • Source: BSE
Earning call transcript
18 Feb, 2026 | 01:57pm • Source: BSE
Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3 & M9 FY26
12 Feb, 2026 | 06:01pm • Source: BSE
Intimation on communication to members regarding Tax Deducted at Source for Interim Dividend
12 Feb, 2026 | 04:34pm • Source: BSE
Submission of Newspaper Publication
12 Feb, 2026 | 02:40pm • Source: BSE
Submission of newspaper publication of Un-Audited Financial Results for the Q3&9M FY2026
12 Feb, 2026 | 02:31pm • Source: BSE